06-Apr-17 In Japanese companies' largest study to date, Takeda will test an experimental dengue vaccine on 20,100 children and adolescents in eight countries in Latin America. Takeda said it has completed enrollment for a 20,000-subject dengue vaccine trial, the largest clinical study in its history, signalling the global ambitions of its vaccine business. [image: ET Healthworld]

27-Mar-17 Mobile Doctor, the korean developer of a pediatric fever management app plans to achieve a total of 1.5 mn downloads at home and abroad this year, with 500,000 of those downloads being in Korea and 1 mn abroad. The company’s data contain information on 670,000 antipyretic drugs, 220 mn pieces of body temperature information, and 90,000 fever symptoms. [image: Mobile Doctor]

21-Mar-17 Olympus has launched a surgical system integration solution Endoalpha, designed to improve work efficiency of endoscopy units and operating rooms inside hospitals in South Korea. Endoalpha allows doctors and medical staff to control the main endoscopic device and supporting medical equipment such as the surgical lights and bed, on a single touch panel. [image: Olympus Korea]

21-Mar-17 Korea's NongHyup Life Insurance has signed an MOU with KT to develop new insurance products and healthcare services using big data and IoT. The companies will launch a product for elderly people in 2018. The product is characterized by smart bands checking their pulse and movements and providing notifications for families, insurers and public health centers. [image: Business Korea]

17-Mar-17 The Korean company GEOMC and Danish sound specialist company AUDIOWISE have jointly developed a sound therapy solution aimed at reducing symptoms of depression, sleep disturbance, pain, anger, and other similar side effects of prolonged stress. The technology is being tested at Seoul National University’s research centers to provide empirical proof of effectiveness. [image: Business Korea]